Restriction Enzyme Analysis of Ribosomal DNA Shows that Candida inconspicua Clinical Isolates Can Be Misidentified as Candida norvegensis with Traditional Diagnostic Procedures

Journal of Clinical Microbiology

Volumn 41, Issue 11, 2003, Pages 5250-5253

  Majoros, L ^a,c   Kardos, G ^a   Belak A ^b   Maraz A ^b   Asztalos, L ^a   Csanky E ^a   Barta, Z ^a   Szabo B ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SZENT ISTVÁN UNIVERSITY   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; FLUCONAZOLE; RIBOSOME DNA;

ANIMAL CELL; ARTICLE; CANDIDA; CANDIDA INCONSPICUA; CANDIDA NORVEGENSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DNA DETERMINATION; ENZYME ANALYSIS; ENZYME SPECIFICITY; FUNGUS HYPHAE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GENE AMPLIFICATION; HUMAN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; SPECIES DIFFERENTIATION;

CANDIDA; CANDIDIASIS; DNA, RIBOSOMAL; HUMANS; INPATIENTS; OUTPATIENTS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REPRODUCIBILITY OF RESULTS; RESTRICTION MAPPING;

ANIMALIA; CANDIDA; CANDIDA INCONSPICUA; FUNGI; PICHIA NORVEGENSIS;

EID: 0242593781     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.11.5250-5253.2003     Document Type: Article

References (22)

1. Baily, G. G., C. B. Moore, S. M. Essayag, S. de Wit, J. P. Burnie, and D. W. Denning. 1997. Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 25:161-163.
2. Essayag, S. M., G. G. Baily, D. W. Denning, and J. P. Burnie. 1996. Karyotyping of fluconazole resistant yeasts with phenotype reported as Candida krusei or Candida inconspicua. Int. J. Syst. Bacteriol. 46:35-40.
3. Fidel, P. L., Jr., J. A. Vazquez, and J. D. Sobel. 1999. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 12:80-96.
4. Fridkin, S. K., and W. R. Jarvis. 1996. Epidemiology of nosocomial fungal infections. Clin. Microbiol. Rev. 9:499-511.
5. Hoffman, C., and F. Winston. 1987. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 57:267-272.
6. Kontoyiannis, D. P., and R. E. Lewis. 2002. Antifungal drug resistance of pathogenic fungi. Lancet 359:1135-1144.
7. Kurtzman, C. P. 1998. Issatchenkia Kudryavtsev emend. Kurtzman, Smiley and Johnson, p. 221-226. In C. P. Kurtzmann and J. W. Fell (ed.), The yeasts, a taxonomic study. Elsevier, Amsterdam, The Netherlands.
8. Kurtzman, C. P. 1998. Pichia E. C. Hansen emend. Kurtzman, p. 273-352. In C. P. Kurtzmann and J. W. Fell (ed.). The yeasts, a taxonomic study. Elsevier, Amsterdam, The Netherlands.
9. Majoros, L., G. Kardos, I. Pócsi, and B. Szabó. 2002. Distribution and susceptibility of Candida species isolated in the Medical University of Debrecen. Acta Microbiol. Immunol. Hung. 49:351-361.
10. Meyer, S. A., R. W. Payne, and D. Yarrow. 1998. Candida Berkhout, p. 454-573. In C. P. Kurtzmann and J. W. Fell (ed.), The yeasts, a taxonomic study. Elsevier, Amsterdam, The Netherlands.
11. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard M27-A. National Committee for Clinical Laboratory Standards Wayne, Pa.
12. Nho, S., M. J. Anderson, C. B. Moore, and D. W. Denning. 1997. Species differentiation by internally transcribed spacer PCR and Hha1 digestion of fluconazole-resistant Candida krusei, Candida inconspicua, and Candida norvegensis strains. J. Clin. Microbiol. 35;1036-1039.
13. Odds, F. C., M. G. Rinaldi, C. L. Cooper, Jr., A. Fothergill, L. Pasarell, and M. R. McGinnis. 1997. Candida and Torulopsis: a blinded evaluation of use of pseudohypha formation as basis for identification of medically important yeasts. J. Clin. Microbiol. 35:313-316.
14. Orozco, A. S., L. M. Higginbotham, C. A. Hitchcock, T. Parkinson, D. Falconer, A. S. Ibrahim, M. A. Ghannoum, and S. G. Filler. 1998. Mechanism of fluconazole resistance in Candida krusei. Antimicrob. Agents Chemother. 42:2645-2649.
15. Samaranayake, Y. H., and L. P. Samaranayake. 1994. Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen. J. Med. Microbiol. 41:295-310.
16. Sandven, P., K. Nilsen, A. Digranes, T. Tjade, and J. Lassen. 1997. Candida norvegensis: a fluconazole-resistant species. Antimicrob. Agents Chemother. 41:1375-1376.
17. Sullivan, D. J., M. C. Henman, G. P. Moran, L. C. O'Neill, D. E. Bennett, D. B. Shanley, and D. C. Coleman. 1996. Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J. Med. Microbiol. 44:399-408.
18. Szabó, B., L. Majoros, and C. Miszti. 2000. Microbiological diagnosis of fungal infections, p. 198-213. In L. Maródi (ed.), Emerging infectious diseases in Eastern-Central Europe. Medicina Publishing House Co., Budapest, Hungary.
19. Warren, N. G., and H. J. Shadomy. 1991. Yeasts of medical importance, p. 617-629. In A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
20. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.
21. White, T. J., T. Bruns, S. Lee, and J. Taylor. 1990. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics, p. 315-322. In M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White (ed.), PCR protocols: a guide to methods and applications. Academic Press, Inc., San Diego, Calif.
22. Williams, D. W., M. J. Wilson, M. A. O. Lewis, and J. C. Potts. 1995. Identification of Candida species by PCR and restriction fragment length polymorphism analysis of intergenic spacer regions of ribosomal DNA. J. Clin. Microbiol. 33:2476-2479.